FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

Data Compilation
#PharmaFlow

Stock Recap
#PipelineProspector

memantine.HCl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

100 API Suppliers, 33 USDMF, 2 CEP/COS, 11 JDMF, 13 EU WC, 32 KDMF, 29 NDC API, 43 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

INTERMEDIATES

14 Intermediate Suppliers

14 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

641 FDF Dossiers, 129 FDA Orange Book, 402 Europe, 12 Canada, 14 Australia, 8 South Africa, 76 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 5MG, CAPSULE, EXTENDED RELEASE;ORAL - 14MG, CAPSULE, EXTENDED RELEASE;ORAL - 21MG, CAPSULE, EXTENDED RELEASE;ORAL - 28MG, CAPSULE, EXTENDED RELEASE;ORAL - 7MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 2 Rochem International Inc, 8 SPI Pharma, 1 Pharm-RX Chemical, 5 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 4 Kirsch Pharma, 1 Panvo Organics, 4 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 Avesta Pharma, 26 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 9 Gangwal Chemicals, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 25 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 27 Roquette, 8 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

66 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 31 Controlled & Modified Release, 31 Granulation, 31 Direct Compression, 30 Disintegrants & Superdisintegrants, 25 Thickeners and Stabilizers, 25 Film Formers & Plasticizers, 24 Lubricants & Glidants, 21 Topical, 20 Taste Masking, 19 Solubilizers, 18 Parenteral, 13 Co-Processed Excipients, 10 Chewable & Orodispersible Aids, 9 Empty Capsules, 6 Emulsifying Agents, 6 API Stability Enhancers, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 86 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 46 Regulatory FDF Prices, 12 Annual Reports

MARKET PLACE

16 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

36 US Patents, 2 US Exclusivities, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 23 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/01/2026	Olpha	Latvia	Eltek Pharmachem Co., Ltd.	20200522-209-J-377	memantine hydrochloride	2020-05-22	JSC OlainFarm	Latvia	5, Rupnicu Street, Olaine, LV-2114, Latvia
29/01/2026	Alembic Pharmaceuticals Limited	India	Youngjin Pharmaceutical Co., Ltd.	20190326-209-J-197(1)	memantine hydrochloride	2020-08-20	Alembic Pharmaceuticals Limited (API Unit-1)	India	AT-Panelav, Tal-Halol, City : Panelav, Dist : Panchmahal, Gujarat State, India

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Memantine.HCl

memantine.HCl

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

100 API Suppliers

33 USDMF

2 CEP/COS

11 JDMF

13 EU WC

32 KDMF

29 NDC API

43 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

INTERMEDIATES

14 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

641 FDF Dossiers

129 FDA Orange Book

402 Europe

12 Canada

14 Australia

8 South Africa

76 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG

TABLET;ORAL - 5MG

CAPSULE, EXTENDED RELEASE;ORAL - 14MG

CAPSULE, EXTENDED RELEASE;ORAL - 21MG

CAPSULE, EXTENDED RELEASE;ORAL - 28MG

CAPSULE, EXTENDED RELEASE;ORAL - 7MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

2 Rochem International Inc

8 SPI Pharma

1 Pharm-RX Chemical

5 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

8 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

4 Kirsch Pharma

1 Panvo Organics

4 ACG Worldwide

8 Actylis

1 Aeon Procare

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

1 Avesta Pharma

26 BASF

1 Bioplus Life Sciences

1 CD Formulation

2 Clariant

11 Corel Pharma Chem

7 DFE Pharma

1 Esteem Industries

2 Finar

9 Gangwal Chemicals

5 Ideal Cures

4 Ingredion Pharma Solutions

25 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

12 Microlex e.U

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

4 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

27 Roquette

8 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

CAPSULE, EXTENDED RELEASE;ORAL - 7MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons